Lansoprazole for maintenance of remission of erosive oesophagitis (Q34636638)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Lansoprazole for maintenance of remission of erosive oesophagitis	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Lansoprazole for maintenance of remission of erosive oesophagitis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

author name string

James W Freston

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

Robert L Jackson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

Bidan Huang

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

E David Ballard

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

publication date

1 January 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

volume

62

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

page(s)

1173-1184

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

cites work

Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for therapeutic equivalence of lansoprazole 30mg and esomeprazole 40mg in the treatment of erosive oesophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety profile of Lansoprazole: the US clinical trial experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of five maintenance therapies for reflux esophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological Management of Gastro-Oesophageal Reflux Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). Dutch Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term management of gastroesophageal reflux disease and its complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms and disease severity in gastro-oesophageal reflux disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptic strictures of the esophagus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rolling review: gastro-oesophageal reflux disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole and oesophageal stricture

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reflux esophagitis in patients with Zollinger-Ellison syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Rationale for Continuous Maintenance Treatment of Reflux Esophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life of patients with acute erosive reflux esophagitis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and natural history of gastro-oesophageal reflux disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance during dosing with H2-receptor antagonists. An overview

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Recurrences of Erosive Reflux Esophagitis: A Cost-Effectiveness Analysis of Maintenance Proton Pump Inhibition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12010078

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-200262080-00004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

Dimensions Publication ID

1034661290

0 references

PubMed publication ID

12010078

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12010078

retrieved

3 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34636638&oldid=2196901017"